0

Malignant Mesothelioma

Advances in Pathogenesis, Diagnosis, and Translational Therapies

Erschienen am 14.06.2005, 1. Auflage 2005
213,99 €
(inkl. MwSt.)

Lieferbar innerhalb 1 - 2 Wochen

In den Warenkorb
Bibliografische Daten
ISBN/EAN: 9780387229492
Sprache: Englisch
Umfang: xxvi, 854 S., 178 s/w Illustr., 854 p. 178 illus.
Format (T/L/B): 3.8 x 26 x 18.5 cm
Einband: gebundenes Buch

Beschreibung

MALIGNANT MELANOMA is a complete bench to beside resource for active surgeons and pulmonologists, biomedical researchers, and public health investigators working in the challenging arena of malignant mesothelioma, in all its variants.Includes supplementary material: sn.pub/extras

Produktsicherheitsverordnung

Hersteller:
Springer Verlag GmbH
[email protected]
Tiergartenstr. 17
DE 69121 Heidelberg

Autorenportrait

InhaltsangabeCarcinogenesis.- The History of Mesothelioma.- Asbestos-Induced Mesothelioma.- SV40-Mediated Oncogenesis.- Mesothelioma Carcinogenesis: In Vivo Models.- Mesothelial and Mesothelioma Cell Lines.- Molecular Genetics.- Cytogenetics of Malignant Mesothelioma.- Growth Factors and Malignant Mesothelioma.- Oncogenes and Tumor Suppressor Genes in Malignant Mesothelioma.- Angiogenesis and Mesothelioma.- Immune Status and Mesothelioma.- Extracellular Matrix and Mesothelioma: Some Clues to the Invasive Behavior of Mesothelioma.- Genomics and Proteomics in Mesothelioma.- Epidemiology.- Asbestos Mineralogy and Health Effects.- Molecular Epidemiology of Mesothelioma.- Malignant Mesothelioma and Erionite.- Determination of Asbestos Exposure by Pathology and Clinical History.- Mesothelioma and Asbestos Exposure.- From Monkey to Man: The Epidemiologic Evidence of an Association Between Simian Virus 40 and Malignancy.- Causes and Prevention of Technical Artifacts When Studying Simian Virus 40 (SV40) in Human Mesotheliomas.- Molecular Detection of Siman Virus 40 in Human Mesothelioma.- Malignant Mesothelioma Following Radiation.- Genetics and Human Mesothelioma.- Clinical Presentation.- Clinicians' Approach to Mesothelioma.- Clinical Presentation and Natural History of Mesothelioma: Pleural and Pericardial.- Clinical Presentation and Natural History of Mesothelioma: Abdominal.- Staging of Mesothelioma.- Prognostic Factors in Mesothelioma.- Imaging and Endoscopy.- Radiologic Assessment of Mesothelioma.- Endoscopic Imaging.- Pathology.- Benign Mesotheliomas, Mesothelial Proliferations, and Their Possible Association with Asbestos Exposure.- Cytology of Malignant Mesothelioma.- Immunohistochemistry.- Malignant Mesothelioma Electron Microscopy.- Rare Variants of Mesothelioma.- Differentiating Sarcomas from Mesotheliomas.- Diagnosis of Synovial Sarcoma of the Pleura and Differentiation from Malignant Mesothelioma.- Pitfalls in the Diagnosis of Malignant Mesothelioma.- Treatment.- Management of Benign Variants of Mesothelioma.- First-Line Chemotherapy for Malignant Pleural Mesothelioma.- Second-Line Chemotherapy.- Treatment of Mesothelioma with Radiotherapy.- Multimodality Approaches.- Intrapleural Chemotherapy with and Without Surgery in Malignant Pleural Mesothelioma (MPM).- Management of Pleural Effusions in Mesothelioma.- Preoperative Chemotherapy and Surgery.- Photodynamic Therapy for Pleural Mesothelioma.- Surgery and Postoperative Radiotherapy.- The Development of the Brigham and Women's Multimodality Treatment Plan for Malignant Pleural Mesothelioma: A Model for Improving the Treatment of Rare Diseases.- Peritoneal Mesothelioma: The Columbia Experience.- Surgery, Hyperthermic Chemoperfusion, and Postoperative Chemotherapy: The National Cancer Institute and Washington Hospital Center Experience.- Pericardial and Tunica Vaginalis Mesothelioma.- Novel Treatment Strategies.- New Target Therapies for Malignant Mesothelioma.- Gene Therapy for Malignant Pleural Mesothelioma.- Immunotherapeutic Approaches and Vaccination Strategies.- Economic Implications.- Economic Aspects of Mesothelioma.

Leseprobe

Leseprobe